NCT02274662 2025-01-16
Expanded Access Protocol Thymus Transplantation
Sumitomo Pharma Switzerland GmbH
Phase 4 Completed
Clinical Trials
3 trialsNCT02231879 2023-04-07
Plerixafor Versus G-CSF in the Treatment of People With WHIM Syndrome
National Institutes of Health Clinical Center (CC)
Phase 2/3 Completed
NCT00553098 2020-02-17
Alemtuzumab, Fludarabine Phosphate, and Total-Body Irradiation Followed by a Donor Stem Cell Transplant in Treating Patients With Immunodeficiency or Other Nonmalignant Inherited Disorders
Fred Hutchinson Cancer Center
Phase 2 Completed